| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MP470 | GDSC1000 | pan-cancer | AAC | 0.095 | 0.004 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | -0.094 | 0.004 |
| mRNA | BEC | CTRPv2 | pan-cancer | AAC | 0.2 | 0.004 |
| mRNA | Pazopanib | GDSC1000 | pan-cancer | AAC | 0.091 | 0.006 |
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.007 |
| mRNA | AZD8055 | CTRPv2 | pan-cancer | AAC | -0.094 | 0.007 |
| mRNA | SB52334 | GDSC1000 | pan-cancer | AAC | 0.086 | 0.007 |
| mRNA | cyanoquinoline 11 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.008 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | 0.14 | 0.008 |
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | -0.088 | 0.008 |